Illinois 103rd Regular Session Status: Died Bipartisan · 1 R · 1 D cosponsors

HB 5103 — INS CD-CANCER SCREENINGS

Last action — House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. Died in session

This bill died with 103rd Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Amends the Illinois Insurance Code. In a provision concerning coverage of certain cancer screenings, adds having a high level of CA-125, as indicated by a blood test screening, to the definition of "at risk for ovarian cancer". Provides that "surveillance tests for ovarian cancer" means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, magnetic resonance imagings (MRIs), x-rays, computed tomography (CT) scans, and CA-125 blood test screenings (instead of an annual screening using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, (iii) pelvic examination).

Bill Text

How this bill changes current law

4 changes Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill expands the definition of 'at risk for ovarian cancer' and clarifies the types of surveillance tests covered under health insurance for ovarian cancer detection.

  • 215 ILCS 5/356u

    annual screening using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, (iii) pelvic examination. → all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, magnetic resonance imagings (MRIs), x-rays, computed tomography (CT) scans, and CA-125 blood test screenings.

    The description of surveillance tests for ovarian cancer is broadened to include various methods instead of limiting it to annual screenings of specific tests.

  • 215 ILCS 5/356u

    having a high level of CA-125, as indicated by a blood test screening. → having a high level of CA-125, as indicated by a blood test screening.

    The definition of 'at risk for ovarian cancer' explicitly adds high CA-125 levels as a risk factor but the wording itself remains unchanged.

  • 215 ILCS 5/356u

    female insureds who are at risk for ovarian cancer. → insureds who are at risk for ovarian cancer.

    The language is updated to use 'insureds' instead of 'female insureds' for inclusivity.

  • 215 ILCS 5/356u

    male insureds upon the recommendation of a physician licensed to practice medicine in all its branches for: → insureds upon the recommendation of a physician licensed to practice medicine in all its branches for:

    The language is updated to use 'insureds' instead of 'male insureds' for inclusivity.

Amendments

1 amendment

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee

  2. Rule 19(a) / Re-referred to Rules Committee

  3. To Insurance Main Subcommittee

  4. House Committee Amendment No. 1 Rules Refers to Insurance Committee

  5. House Committee Amendment No. 1 Referred to Rules Committee

  6. House Committee Amendment No. 1 Filed with Clerk by Rep. Jed Davis

  7. Assigned to Insurance Committee

  8. Referred to Rules Committee

  9. First Reading

  10. Added Chief Co-Sponsor Rep. Kelly M. Cassidy

  11. Filed with the Clerk by Rep. Jed Davis

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 1 co-sponsors · 181 not signed on

Sponsors (1)

Co-sponsors (1)

Not signed on (181)

181 members have not signed on to this bill.

Show all 181 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 5103 do?
Amends the Illinois Insurance Code. In a provision concerning coverage of certain cancer screenings, adds having a high level of CA-125, as indicated by a blood test screening, to the definition of "at risk for ovarian cancer". Provides that "surveillance tests for ovarian cancer" means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, magnetic resonance imagings (MRIs), x-rays, computed tomography (CT) scans, and CA-125 blood test screenings (instead of an annual screening using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, (iii) pelvic examination).
Who sponsors HB 5103?
HB 5103 is sponsored by Jed Davis (Republican) and Kelly M. Cassidy (Democrat).
What is the current status of HB 5103?
This bill died with 103rd Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 5103?
Track HB 5103 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 5103

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 5103

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →